@article{2731b4da54564334945468019a999864,
title = "Rivaroxaban for treatment of pediatric venous thromboembolism. An Einstein-Jr phase 3 dose-exposure-response evaluation",
keywords = "anticoagulation, bodyweight-adjusted dosing, pediatric patients, pharmacokinetics, rivaroxaban, suspension, venous thromboembolism",
author = "Guy Young and Lensing, {Anthonie W.A.} and Paul Monagle and Christoph Male and Kirstin Thelen and Stefan Willmann and Palumbo, {Joseph S.} and Riten Kumar and Ildar Nurmeev and Kerry Hege and Fanny Bajolle and Philip Connor and Hooimeijer, {H{\'e}l{\`e}ne L.} and Marcela Torres and Chan, {Anthony K.C.} and Gili Kenet and Susanne Holzhauer and Amparo Santamar{\'i}a and Pascal Amedro and Jan Beyer-Westendorf and Ida Martinelli and Massicotte, {M. Patricia} and Smith, {William T.} and Berkowitz, {Scott D.} and Stephan Schmidt and Victoria Price and Prins, {Martin H.} and Dagmar Kubitza",
note = "Publisher Copyright: {\textcopyright} 2020 International Society on Thrombosis and Haemostasis",
year = "2020",
month = jul,
day = "1",
doi = "10.1111/jth.14813",
language = "English",
volume = "18",
pages = "1672--1685",
journal = "Journal of Thrombosis and Haemostasis",
issn = "1538-7933",
publisher = "Wiley-Blackwell",
number = "7",
}